• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 6 hours
Witness status adds new twist in Novartis probe ekathimerini.com15:09 19-Apr-21
In the last 7 days
Novartis AG – Consensus Indicates Potential 20.7% Upside DirectorsTalk Interviews08:28 16-Apr-21
RE100 initiative hits 300 member milestone BusinessGreen19:07 15-Apr-21
Wugen Appoints Daniel Kemp, Ph.D., as Chief Executive Officer PR Newswire (Press Release)09:01 14-Apr-21
In the last month
Novartis, Artios cancer discovery deal worth up to $1.3bn Outsourcing-Pharma.com09:23 12-Apr-21
Artios Pharma to collaborate with Novartis on DDR cancer therapies European Pharmaceutical Manufacturer07:23 8-Apr-21
Novartis, Artios Pharma Target Cancer in Up-to-$1.3B DDR Collaboration Genetic Engineering and Biotechnology News14:52 7-Apr-21
Novartis AG – Consensus Indicates Potential 22.4% Upside DirectorsTalk Interviews08:04 2-Apr-21
Italy's top court sends Roche-Novartis revocation request to ECJ Thomson Reuters - Practical Law04:13 1-Apr-21
Novartis goes nuclear, again Evaluate Group10:58 30-Mar-21
Novartis Picks New Chief Legal Officer Focused on Diversity Law.com Corporate Counsel12:52 25-Mar-21
view more headlines
19 Apr 20:08

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.